"The Reddit discussion highlights the approval of Novo Nordisk's WegovyÂ® for the treatment of MASH as a significant catalyst for investment in the $MASH sector, reflecting positive sentiment among investors. Key concerns include the potential market competition and the long-term efficacy of the treatment."